Our analysis results concluded that TIPE2 could be considered a tumor suppressor in the initiation and progression of UC and a good indicator for prognosis, which can be used to assess the risk for tumor progression, and as a potential therapeutic target for UC. This evidence concerns the gene TIPE2 and neoplasm.